Internal Medicine

Chemotherapy

Questions discussed in this category

Does the presence of asparaginase antibodies on Granger Genetics testing indicate need to switch asparaginase formulations?

1 Answer available

What is your approach to management of chronic neutropenia in a patient with Sjogren’s who was recently diagnosed with metastatic endometrial cancer and plans to start chemotherapy?

ANC <500

1 Answer available

When using daratumumab in the setting of post-transplant red cell aplasia or post-transplant immune-mediated cytopenias, do you hold the drug for certain ANC parameters?

1 Answer available

How do you manage patients with chemotherapy-induced paronychia?

1 Answer available

How do you manage incidentally identified chemotherapy-associated aortitis/large vessel vasculitis?

1 Answer available

Papers discussed in this category

BJR Case Rep, 2018 Sep 08

A case of aortitis during cisplatin-based chemotherapy for cervical cancer.

Mediterranean journal of rheumatology, 2022 Mar 31

Clinical Phenotype and Mechanisms of Leukopenia/Neutropenia in Patients with Primary Sjögren's Syndrome.

Pediatric blood & cancer, 2015-06

Clinical application of asparaginase activity levels following treatment with pegaspargase.

Leukemia & lymphoma, 2018-08

Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.

Haematologica, 2016 Mar

Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation.

Related Topics in Internal Medicine